0000899243-20-020307.txt : 20200723 0000899243-20-020307.hdr.sgml : 20200723 20200723213140 ACCESSION NUMBER: 0000899243-20-020307 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200723 FILED AS OF DATE: 20200723 DATE AS OF CHANGE: 20200723 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rock Springs Capital Management LP CENTRAL INDEX KEY: 0001595725 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39397 FILM NUMBER: 201044917 BUSINESS ADDRESS: STREET 1: 650 SOUTH EXETER STREET STREET 2: SUITE 1070 CITY: BALTIMORE STATE: MD ZIP: 21202 BUSINESS PHONE: 4102200129 MAIL ADDRESS: STREET 1: 650 SOUTH EXETER STREET STREET 2: SUITE 1070 CITY: BALTIMORE STATE: MD ZIP: 21202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rock Springs Capital Master Fund LP CENTRAL INDEX KEY: 0001735393 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39397 FILM NUMBER: 201044918 BUSINESS ADDRESS: STREET 1: 650 SOUTH EXETER STREET STREET 2: SUITE 1070 CITY: BALTIMORE STATE: MD ZIP: 21202 BUSINESS PHONE: 410-220-0142 MAIL ADDRESS: STREET 1: 190 ELGIN AVENUE CITY: GEORGE TOWN STATE: E9 ZIP: KY1 9001 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rock Springs Capital LLC CENTRAL INDEX KEY: 0001735397 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39397 FILM NUMBER: 201044919 BUSINESS ADDRESS: STREET 1: 650 SOUTH EXETER STREET STREET 2: SUITE 1070 CITY: BALTIMORE STATE: MD ZIP: 21202 BUSINESS PHONE: 410-220-0142 MAIL ADDRESS: STREET 1: 650 SOUTH EXETER STREET STREET 2: SUITE 1070 CITY: BALTIMORE STATE: MD ZIP: 21202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inozyme Pharma, Inc. CENTRAL INDEX KEY: 0001693011 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 475129768 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 321 SUMMER STREET STREET 2: SUITE 400 CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 857-330-4340 MAIL ADDRESS: STREET 1: 321 SUMMER STREET STREET 2: SUITE 400 CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: Inozyme Pharma, LLC DATE OF NAME CHANGE: 20161222 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2020-07-23 0 0001693011 Inozyme Pharma, Inc. INZY 0001595725 Rock Springs Capital Management LP 650 SOUTH EXETER ST. SUITE 1070 BALTIMORE MD 21202 0 0 1 0 0001735393 Rock Springs Capital Master Fund LP C/O WALKERS CORPORATE LIMITED, CAYMAN CO CENTER, 27 HOSPITAL ROAD GEORAGE TOWN E9 KY-1-9008 CAYMAN ISLANDS 0 0 1 0 0001735397 Rock Springs Capital LLC 650 SOUTH EXETER ST. SUITE 1070 BALTIMORE MD 21202 0 0 1 0 Series A-2 Convertible Preferred Stock Common Stock 467884 I See Footnote The Series A-2 Convertible Preferred Stock is convertible into Common Stock on a 7.4730-for-1 basis into the number of shares of Common Stock as shown in Column 3 at any time at the holder's election, and automatically upon the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date. The securities reported herein are held of record by Rock Springs Capital Master Fund LP ("Master Fund"). Rock Springs Capital LLC ("RSC") is the general partner of Rock Springs Capital Management LP ("RSCM") which is the investment manager to Master Fund. RSC and RSCM may therefore be deemed to have or share beneficial ownership of the Series A-2 Convertible Preferred Stock held directly by Master Fund. Exhibit Index: 24.1 Power of Attorney Rock Springs Capital Management LP, By: /s/ Stephen Basso, Attorney-in-Fact 2020-07-23 Rock Springs Capital Master Fund LP, By: /s/ Stephen Basso, Attorney-in-Fact 2020-07-23 Rock Springs Capital LLC, By: /s/ Stephen Basso, Attorney-in-Fact 2020-07-23 EX-24.1 2 attachment1.htm EX-24.1 DOCUMENT

                                                                    Exhibit 24.1

         LIMITED POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATIONS

    Know all by these presents, that the undersigned hereby makes, constitutes
and appoints each of Axel Bolte, Henric Bjarke, and Stephen Basso, signing
singly and each acting individually, as the undersigned's true and lawful
attorney-in-fact with full power and authority as hereinafter described to:

    (1)  execute for and on behalf of the undersigned, in the undersigned's
capacity as an officer, director, and/or stockholder of Inozyme Pharma, Inc.
(the "Company"), Forms 3, 4, and 5 (including any amendments thereto) in
accordance with Section 16(a) of the Securities Exchange Act of 1934, as
amended, and the rules thereunder (the "Exchange Act");

    (2)  do and perform any and all acts for and on behalf of the undersigned
which may be necessary or desirable to prepare, complete and execute any such
Form 3, 4, or 5, prepare, complete and execute any amendment or amendments
thereto, and timely deliver and file such form with the United States Securities
and Exchange Commission (the "SEC") and any stock exchange or similar authority,
including, without limitation, the filing of a Form ID, Update Passphrase, or
any other application materials to enable the undersigned to gain or maintain
access to the Electronic Data Gathering, Analysis and Retrieval system of the
SEC;

    (3)  seek or obtain, as the undersigned's representative and on the
undersigned's behalf, information regarding transactions in the Company's
securities from any third party, including brokers, employee benefit plan
administrators and trustees, and the undersigned hereby authorizes any such
person to release any such information to such attorney-in-fact and approves and
ratifies any such release of information; and

    (4)  take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.

    The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted.  The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming nor
relieving, nor is the Company assuming nor relieving, any of the undersigned's
responsibilities to comply with Section 16 of the Exchange Act.  The undersigned
acknowledges that neither the Company nor the foregoing attorneys-in-fact assume
(i) any liability for the undersigned's responsibility to comply with the
requirement of the Exchange Act, (ii) any liability of the undersigned for any
failure to comply with such requirements, or (iii) any obligation or liability
of the undersigned for profit disgorgement under Section 16(b) of the Exchange
Act.

    This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

    IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 21st day of July, 2020.





                              Rock Springs Capital Management LP
                              By: Rock Springs Capital LLC

                              /s/ Mark Bussard
                              -----------------------------
                              Mark Bussard
                              Member

                              Rock Springs Capital Master Fund LP
                              By: Rock Springs General Partner LLC

                              /s/ Mark Bussard
                              ----------------
                              Mark Bussard
                              Member

                              Rock Springs Capital LLC

                              /s/ Mark Bussard
                              ----------------
                              Mark Bussard
                              Member